Correlation Between BioLine RX and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both BioLine RX and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLine RX and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLine RX and Purple Biotech, you can compare the effects of market volatilities on BioLine RX and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLine RX with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLine RX and Purple Biotech.
Diversification Opportunities for BioLine RX and Purple Biotech
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between BioLine and Purple is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding BioLine RX and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and BioLine RX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLine RX are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of BioLine RX i.e., BioLine RX and Purple Biotech go up and down completely randomly.
Pair Corralation between BioLine RX and Purple Biotech
Assuming the 90 days trading horizon BioLine RX is expected to generate 0.76 times more return on investment than Purple Biotech. However, BioLine RX is 1.31 times less risky than Purple Biotech. It trades about -0.13 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.19 per unit of risk. If you would invest 1,880 in BioLine RX on September 1, 2024 and sell it today you would lose (1,070) from holding BioLine RX or give up 56.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioLine RX vs. Purple Biotech
Performance |
| Timeline |
| BioLine RX |
| Purple Biotech |
BioLine RX and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioLine RX and Purple Biotech
The main advantage of trading using opposite BioLine RX and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLine RX position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| BioLine RX vs. Bezeq Israeli Telecommunication | BioLine RX vs. Brainsway | BioLine RX vs. Mivne Real Estate | BioLine RX vs. Photomyne |
| Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Compugen | Purple Biotech vs. Purple Biotech | Purple Biotech vs. BioLine RX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |